Modified release compositions of milnacipran

Details for Australian Patent Application No. 2003301671 (hide)

International Classifications

Event Publications

10 June 2004 Complete Application Filed

Priority application(s): 60/421,640 25.10.02 US; 60/431,906 09.12.02 US; 60/458,994 28.03.03 US; 60/459,061 28.03.03 US; 60/431,627 05.12.02 US; 60/431,626 05.12.02 US; 60/458,995 28.03.03 US; 60/443,618 29.01.03 US; 60/431,861 09.12.02 US

17 June 2004 Application Open to Public Inspection

Published as AU-B-2003301671

9 February 2006 Application Accepted

Published as AU-B-2003301671

13 April 2006 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 07 Feb 2006. Address for service in Australia - Blake Dawson Waldron Level 39 101 Collins Street Melbourne VIC 3000 2006

17 August 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 07 Feb 2006

17 August 2006 Standard Patent Sealed

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.